top of page

This is your Feature section paragraph. Use this space to present specific credentials, benefits or special features you offer.

Intrommune Therapeutics

Updated: May 22, 2021

Presented by Abhit Singh, MD, MHA VP, Medical Affairs, Intrommune Therapeutics

Intrommune Therapeutics is a specialty bio-pharmaceutical company located in New York, NY. Intrommune is developing a revolutionary new treatment platform for food allergies that is safe, effective and convenient. Intrommune’s first product is a therapy for patients who suffer fro​m peanut allergy. Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 9 million U.S. adults and 6 million U.S. children, who suffer from this life-altering condition.

50 views0 comments

Recent Posts

See All
bottom of page